NCT02324101Unknown不适用
Clinical Trial of Quantitative Detection Kit for Hsp90α in Breast Cancer
适应症
试验速览
- 阶段
- 不适用
- 发起方
- Protgen Ltd
- 入组人数
- 1,100
- 试验地点
- 1
- 主要终点
- Hsp90α Concentration(ng/ml) of plasma
研究概览
简要总结
Detect plasma Hsp90α concentration of breast cancer patients, healthy volunteers, benign breast diseases patients
详细描述
Detect plasma Hsp90α concentration of breast cancer patients, healthy volunteers, benign breast diseases patients, validate accuracy, specificity and sensitivity of Hsp90α kit.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Diagnostic
- 盲法
- None
入排标准
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •breast cancer patients, healthy volunteers, benign breast diseases patients
排除标准
- •Patients who previously received radiotherapy
结局指标
主要结局
Hsp90α Concentration(ng/ml) of plasma
时间窗: 4 months
Detect Hsp90α Concentration(ng/ml) of plasma and calculate the accuracy, specificity and sensitivity of Hsp90α kit
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
Unknown
不适用
Clinical Trial of Quantitative Detection Kit for Hsp90α in Hepatic CancerLiver CancerNCT02324127Protgen Ltd1,100
Unknown
不适用
Clinical Trial of Quantitative Detection Kit for Hsp90α in Colorectal CancerColorectal CancerNCT02324114Protgen Ltd1,100
已完成
不适用
Kinetics of Troponin and BNP in Breast Cancer Chemotherapy With Adriamycin and TrastuzumabBreast CancerNCT01771549Mayo Clinic26
已完成
不适用
Detection of Amplification of Her2 Fluorescent in Situ Hybridization (FISH) in Breast Tissue SectionsBreast CancerNCT01066507Applied Spectral Imaging Ltd.126
已完成
不适用
Evaluation of Blood/Imaging Based Biomarkers, Aromatase Inhibitor Induced Musculoskeletal SyndromeAromatase Inhibitor Induced Musculoskeletal Syndrome (AIMSS)Breast CancerNCT03665077University of Arizona28